INSPECS Group plc Share Price
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
10:05:21 28/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 90.00 GBX | 0.00% |
|
0.00% | +25.87% |
| 10/09 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 10/09 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 13Cr 12Cr 11Cr 9.83Cr 18Cr 1.25TCr 19Cr 129.72Cr 52Cr 651.83Cr 49Cr 48Cr 2.07TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 8.67Cr 7.78Cr 7.19Cr 6.51Cr 12Cr 825.88Cr 12Cr 86Cr 34Cr 432.17Cr 33Cr 32Cr 1.37TCr | EV / Sales 2026 * |
0.32x | EV / Sales 2027 * | 0.31x |
| Free-Float |
10.75% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 04/03 | Form 8.3 - Inspecs Group Plc | AQ |
| 11/02 | Form 8.3 - Inspecs Group Plc | AQ |
| 09/02 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 28/01 | Form 8.3 - Inspecs Group Plc | AQ |
| 07/01 | Form 8.3 - Inspecs Group Plc | AQ |
| Current month | -3.74% | ||
| 1 month | -3.74% | ||
| 3 months | -6.25% | ||
| 6 months | +7.78% | ||
| Current year | +25.87% |
| 1 week | 87 |  | 93 |
| 1 month | 87 | | 93 |
| Current year | 60 | | 105 |
| 1 year | 60 | | 105 |
| 3 years | 37 | | 105 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 01/12/2022 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Peck
BRD | Director/Board Member | 62 | 10/01/2020 |
Angela Farrugia
BRD | Director/Board Member | 61 | 12/05/2020 |
Luke Johnson
BRD | Director/Board Member | 64 | 19/05/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/06/25 | Free | Chief Executive Officer | 2,50,000 | 0.2459% | ||
| 04/06/25 | Free | Chief Executive Officer | 1,50,000 | 0.1475% | ||
| 08/11/22 | Buy | Chief Executive Officer | 8,33,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +57.89% | +28.57% | 13Cr | |
| -0.45% | +2.12% | -18.93% | +10.54% | 18TCr | |
| +0.86% | +2.15% | -19.13% | +16.07% | 12TCr | |
| +0.88% | +1.88% | +1.66% | +36.51% | 12TCr | |
| -2.26% | +2.24% | -44.03% | +5.76% | 9.31TCr | |
| -0.31% | -4.72% | -3.36% | +72.86% | 6.21TCr | |
| +0.08% | +0.34% | +10.96% | +84.78% | 5.59TCr | |
| +0.07% | +0.42% | +5.94% | -22.43% | 5.31TCr | |
| +0.30% | +1.70% | -11.26% | +43.83% | 4.42TCr | |
| +0.10% | +3.08% | -3.06% | -8.71% | 3.36TCr | |
| Average | -0.06% | +2.05% | -2.33% | +26.78% | 7.51TCr | |
| Weighted average by Cap. | -0.10% | +2.37% | -12.48% | +24.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27Cr 24Cr 22Cr 20Cr 37Cr 2.54TCr 38Cr 264.97Cr 105.54Cr 1.33TCr 100.26Cr 98Cr 4.23TCr | 28Cr 25Cr 23Cr 21Cr 39Cr 2.64TCr 39Cr 274.43Cr 109.31Cr 1.38TCr 103.84Cr 101.65Cr 4.38TCr |
| Net income | - | - |
| Net Debt | -4.41Cr -3.95Cr -3.66Cr -3.31Cr -6.19Cr -419.78Cr -6.26Cr -44Cr -17Cr -219.66Cr -17Cr -16Cr -697.35Cr | -4.54Cr -4.08Cr -3.77Cr -3.41Cr -6.38Cr -432.76Cr -6.45Cr -45Cr -18Cr -226.46Cr -17Cr -17Cr -718.92Cr |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | GBX 90.00 | 0.00% | 5,668 |
| 27/26/27 | GBX 90.00 | 0.00% | 0 |
| 26/26/26 | GBX 90.00 | 0.00% | 0 |
| 23/26/23 | GBX 90.00 | 0.00% | 6,928 |
| 22/26/22 | GBX 90.00 | 0.00% | 4,004 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.198USD
Average target price
0.8180USD
Spread / Average Target
-31.72%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
